ENDEVICA BIO
Endevica Bio create best-in-class peptide drug candidates with better safety and efficacy properties than other drugs in the same class. Endevica’s technology platform, protected by a family of patents and pending applications, allows for the modification of peptides to perform with improved half-life, oral activity, and the ability to cross the blood-brain barrier.
ENDEVICA BIO
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
Columbia, Missouri, United States
Country:
United States
Website Url:
http://www.tcitherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(573) 881-5080
Email Addresses:
[email protected]
Total Funding:
4 M USD
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Current Employees Featured
Founder
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Endevica Bio
Centennial Investors
Centennial Investors investment in Series A - Endevica Bio
Official Site Inspections
http://www.tcitherapeutics.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 3.33.152.147
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Endevica Bio"
our team - ECI Therapeutics
Our team is comprised of experts in hematology, ophthalmology, biomedical/ biomaterial engineering, quality/ regulatory affairs, project management, drug design, pre-clinical trials, and device development.See details»
about us - ECI Therapeutics
ECI researches, develops, and creates breakthrough products – for ophthalmic use, diabetic ulcer treatment, and wound and burn care – that leverage blood and chitosan to help patients.See details»
ECI Therapeutics - Crunchbase Company Profile & Funding
ECI Therapeutics researches, develops, and creates medicinal products for diabetic, ulcer, wound, and burn care.See details»
ECI Therapeutics | LinkedIn
ECI Therapeutics | 588 followers on LinkedIn. A biopharma company dedicated to the development and commercialization of specialty serum-derived ophthalmic drugs. | ECI is a biopharma company ...See details»
ECI Therapeutics - Org Chart, Teams, Culture & Jobs | The Org
View ECI Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
ECI Therapeutics - Company Profile - Tracxn
Oct 21, 2024 ECI Therapeutics - Developer of therapeutics to treat multiple diseases. Raised a total funding of $2.11M over 2 rounds.See details»
ECI Therapeutics Overview | SignalHire Company Profile
ECI is a biopharma company dedicated to the development, commercialization, and marketing of specialty human plasma/serum-derived drugs for ophthalmic conditions; wound healing; and …See details»
Eci Therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Jun 27, 2024 Explore Eci Therapeutics with its drug pipeline, therapeutic area, technology platform, .See details»
ECI (Biotechnology) Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for ECI (Biotechnology). Use the PitchBook Platform to explore the full profile.See details»
investors - ECI Therapeutics
Learn more about ECI and the market we aim to serve including addressable population, target product profiles and key growth trends. Our development pipeline includes drug candidates that will meet critical needs.See details»
Carlie Pedersen - Chief of Staff and Director of …
Currently serving as Vice President. Advise and oversee the overall direction and strategies of Camp Rainbow Gold. Help to direct the organization through the COVID pandemic.See details»
ECI Therapeutics - Products, Competitors, Financials, Employees ...
ECI Therapeutics develops therapeutic products in the biopharmaceutical sector, specifically targeting ophthalmic conditions, wound healing, and burn care. Use the CB Insights Platform …See details»
Elan Weiner - Greater Boston | Professional Profile | LinkedIn
As the CEO of ECI Therapeutics, I lead a biopharma company that leverages a novel… · Location: Greater Boston. 500+ connections on LinkedIn. View Elan Weiner’s profile on …See details»
Therapeutics Incorporated - Crunchbase Company Profile & Funding
Therapeutics Incorporated may be growing as evidenced by the reported increase in revenue, which is a strong indicator of financial health and market acceptance. The company's revenue …See details»
our mission - ECI Therapeutics
Our actions are driven by three core principles: Prioritizing patients, fostering a positive work environment, and embodying our values. Our mission: to develop safe and effective innovative …See details»
TCI Peptide Therapeutics - Craft
See insights on TCI Peptide Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Moving from dose to concentration: as easy as TCI!
Jun 30, 2020 To encourage a favourable stance from regulatory agencies such as the US Food and Drug Administration (FDA), advocates of target-controlled infusion (TCI) systems have …See details»
FDA Approves First Cellular Therapy to Treat Patients with …
The FDA approved Amtagvi, the first cellular therapy for the treatment of adults with unresectable or metastatic melanoma.See details»
Privacy Policy - ECI Therapeutics
For example, we may provide your personal information to an organization in order to complete a service (e.g., shipping an order, sending mailings you have requested), to assist us in …See details»